Draft NICE guidelines on type-2 diabetes have backed second-line use of DPP-4 inhibitors
Intensive treatment using multiple drug combinations remains the best way of treating type-2...GPs already offer multiple drug treatments to diabetic patients as part of the diabetes domain ... halve the number of cardiovascular deaths. Researchers randomly assigned 160 patients with diabetes ... cholesterol, BP and blood glucose levels than those in the conventional group. Dr Brian Karet, diabetes lead ...
type-2 diabetics, claim UK researchers....-monitoring for non-insulin treated type-2 diabetes is commonly recommended, but evidence of effectiveness is inconclusive.The researchers id-entified 453 type-2 diabetes patients aged 25 and over, who managed ... -insulin-treated type-2 diabetes may be better directed to supporting other health-related behaviours. BMJ Online 2007 ...
Type-2 diabetes may be linked to abnormalities in a person's body clock and sleep patterns ... that increases the risk of diabetes by 20 per cent. The findings suggest that type-2 diabetes could be tackled ... whether the presence of the mutation could increase the risk of type-2 diabetes by comparing the genetic ...
Doubt has been cast on the value of thiazolidinediones in type-2 diabetes by US researchers....A review of available literature showed older oral agents for blood glucose control in type-2 diabetes are as effective or superior to the newer, more expensive agents such as thiazolidinediones ... -cholesterol, and no other drugs appeared to affect lipid levels. Current NICE guidelines on glucose control in type-2 ...
Lifestyle interventions may be as effective as drug therapy at preventing type-2 diabetes...Follow-up data from the Finnish Diabetes Prevention Study showed a four-year intensive lifestyle intervention reduced the risk of type-2 diabetes by 43 per cent. During active intervention, the risk of type-2 ... or impaired fasting glucose transferring to type-2 diabetes by 60 per cent. County Down GP Dr Colin Kenny ...
Group education for patients with type-2 diabetes has been successful in changing attitudes...The research is the first to back the recommendation of group-structured education, featured in the diabetes NSF. For the study, 824 adults with newly diagnosed type-2 diabetes were recruited from 207 ... was DESMOND (Diabetes Education and Self Management for Ongoing and Newly Diagnosed). It tries to elicit ...
Taking the diabetes drug pioglitazone could help to lower rates of atherosclerosis in type-2...of the two drugs on the rate of progression of coronary atherosclerosis in 543 patients with type-2 diabetes ... This is the first time that a diabetes drug has been shown to lower the rate of risk ... with diabetes. The findings of the PERISCOPE trial, presented this week at the American Cardiology Conference ...
Diabetes - Expert GP says new drugs could mean updated NICE guidance is out of date before the end...Roles for the whole range of new type-2 diabetes drugs, including DPP-4 inhibitors and exenatide, have been set out in new NICE type-2 diabetes guidelines. Sitagliptin and vildagliptin have been ... their diabetes control, NICE says. The guidelines recommend the use of pioglitazone or rosiglitazone as second ...
A pill to 'cure' type-2 diabetes could soon be developed, according to newspaper reports....this mechanism may affect glucose intolerance, researchers induced mice to develop type-2 diabetes by feeding ... type-2 diabetes in mice. Researchers said human trials were planned. Diabetes UK said ... compromised in human patients with type-2 diabetes is something we have to check,' he said. He said plans ...
Sort results by: date | relevance
Click 
to remove filters
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
GPs practising in the UK can request to receive free copies of GP by completing our online registration form. For paid subscriptions to GP visit our subscriptions site.
To contact members of the GP team click here.
Haymarket Business Media © 1957 – 2012 | Terms & Conditions | Contact us
